Vancouver, British Columbia – TheNewswire - October 6, 2022 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the following correction to its news release dated October 3, 2022.  

The effective date of the grant of 3,000,000 stock options of the Company announced on October 3, 2022 is October 5, 2022.  The expiry date of these options is October 5, 2027.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.